RxDoctor Payments DataLook up a doctor →

Jamie Rhoads, MD

Dermatology · Murray, UTNPI 1104093392

Payments from drug & device makers

$2,512,985in general payments, 2019–2025

Across 448 payments — averaging $5609.34 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$867K
  • Amgen$366K
  • Regeneron$308K
  • Pfizer$296K
  • Eli Lilly$275K
  • Incyte Corporation$159K
  • plus $241K from 8 others

General payments by program year

20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
AbbVie83$867,285
Amgen11$366,270
Regeneron140$307,613
Pfizer41$296,321
Eli Lilly18$274,936
Incyte Corporation40$159,177
Boehringer Ingelheim10$88,486
Argenx US, Inc.31$77,460
Lilly USA, LLC50$48,237
Merck1$17,408
Boehringer Ingelheim International GmbH17$8,329
E.r. Squibb & Sons, L.L.C.1$1,095
Johnson & Johnson4$354
AstraZeneca1$14

How this compares

$2,512,985 in reported general payments places this provider in the 95th percentile of 163 dermatology providers in Utah.

See all dermatology providers in Utah

Medicare billing

Part B allowed, 2024
$42,680
Medicare patients
136
Services billed
777

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other dermatology in Murray

See the full list for Utah

Where these figures come from

Is this you, or does something look wrong? →